Prescription drug · UNAPPROVED DRUG OTHER
OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C (Hydroquinone) NDC 62032-122
Hydroquinone 40 mg/mL · Liquid · Topical · Obagi Cosmeceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62032-122-10 | 6203201221062032012210 | 1 BOTTLE, GLASS in 1 CARTON (62032-122-10) / 30 mL in 1 BOTTLE, GLASSMarketed from Jan 1, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN CSuffix: SKIN LIGHTENING SERUM WITH VITAMIN C
- Generic name (nonproprietary)
- hydroquinone
- Active ingredients
- Hydroquinone — 40 mg/mL
- Dosage form
- Liquid
- Route
- Topical
- Labeler
- Obagi Cosmeceuticals LLCNDC labeler code 62032
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Depigmenting Activity (Physiologic effect)Melanin Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 62032-122_a65d3895-8496-45b2-b273-70e6d4da4a02SPL ID a65d3895-8496-45b2-b273-70e6d4da4a02SPL set ID 18803dfb-5b9c-48cd-a838-519c8bac3361UNII XV74C1N1AEUPC 0362032122106
- Pharmacologic class
- Melanin Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462032012210followed by a unit qualifier and the quantityPackage 62032-0122-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE The gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.
Excerpt only. Read the full label for complete information.
About NDC 62032-122
- What is NDC 62032-122?
- 62032-122 is the product NDC for OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C, Hydroquinone 40 mg/mL liquid, listed with the FDA by Obagi Cosmeceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C (Hydroquinone).
- What is the active ingredient?
- Hydroquinone.
- Who is the labeler?
- Obagi Cosmeceuticals LLC, NDC labeler code 62032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.